Results
625
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
625 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €951.40 | 2.1% | 125.6% | €41.3b | €901.79 | PE60.3x | E30.5% | 0.6% | Capital Goods | ||
ALNY | US$248.94 | -2.9% | 56.9% | US$32.4b | US$304.61 | PS14.3x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$168.91 | -9.3% | 28.6% | US$54.5b | US$198.57 | PE77.3x | E41.4% | 2.7% | Diversified Financials | ||
ONON | US$48.75 | -6.3% | 48.7% | US$15.5b | US$63.49 | PE111.1x | E29.8% | n/a | Consumer Durables | ||
NVDA | US$130.28 | -6.2% | 64.7% | US$3.3t | US$171.34 | PE50.6x | E21.6% | 0.03% | Semiconductors | ||
600760 | CN¥44.70 | 0.2% | 16.9% | CN¥125.0b | CN¥53.90 | PE50.1x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$109.10 | -3.0% | 446.6% | HK$145.5b | HK$102.94 | PE88.5x | E37.1% | 0.3% | Retail | ||
6181 | HK$530.00 | 12.8% | n/a | HK$89.5b | HK$502.64 | PE103.2x | E43.2% | n/a | Consumer Durables | ||
NU | US$11.02 | -19.6% | 2.8% | US$52.1b | US$14.59 | PB6.9x | E27.6% | n/a | Banks | ||
300308 | CN¥111.35 | -2.0% | -3.7% | CN¥126.5b | CN¥192.85 | PE26.6x | E33.3% | 0.3% | Tech | ||
ALAB | US$84.63 | -3.7% | n/a | US$13.9b | US$125.03 | PS34.6x | E61.1% | n/a | Semiconductors | ||
A012450 | ₩682,000.00 | 6.1% | 242.8% | ₩30.3t | ₩614,150.00 | PE45.9x | E30.0% | 0.3% | Capital Goods | ||
2345 | NT$680.00 | -10.3% | 35.5% | NT$394.0b | NT$870.00 | PE39.1x | E33.7% | 1.5% | Tech | ||
A196170 | ₩393,500.00 | -0.4% | 149.8% | ₩20.4t | ₩565,000.00 | PS282x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
2382 | NT$254.50 | -3.8% | 9.5% | NT$1.0t | NT$358.05 | PE18.1x | E20.8% | 3.5% | Tech | ||
300502 | CN¥110.70 | -10.6% | 73.7% | CN¥80.4b | CN¥161.36 | PE41.2x | E36.6% | 0.1% | Tech | ||
ITCI | US$128.57 | 0.6% | 79.7% | US$13.7b | US$132.00 | PS20.1x | E50.2% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$51.61 | 7.7% | -41.1% | US$32.8b | US$47.88 | PE25x | E27.6% | n/a | Tech | ||
600989 | CN¥15.80 | -2.8% | 3.5% | CN¥115.9b | CN¥21.74 | PE18.4x | E38.5% | 1.8% | Materials | ||
BAM | CA$82.83 | -2.3% | 49.4% | CA$134.5b | CA$76.13 | PE173.2x | E67.5% | 3.0% | Diversified Financials | ||
PME | AU$283.51 | 1.3% | 183.8% | AU$29.6b | AU$254.50 | PE301.4x | E23.6% | 0.2% | Healthcare | ||
SYM | US$24.38 | -9.9% | -40.5% | US$14.4b | US$34.32 | PS1.4x | E84.6% | n/a | Capital Goods | ||
6669 | NT$1,935.00 | -11.2% | -8.7% | NT$379.1b | NT$3,002.06 | PE18.7x | E24.0% | 2.2% | Tech | ||
BAJFINANCE | ₹8,488.80 | 0.3% | 29.5% | ₹5.2t | ₹8,664.82 | PE32.9x | E23.4% | 0.4% | Diversified Financials |